Your session is about to expire
← Back to Search
Geotagged Social Networking for Physical Disabilities (RECTECHIV Trial)
RECTECHIV Trial Summary
This trial aims to address the multilevel barriers and facilitators to physical activity for people with physical disabilities by developing an innovative person-centered geotagged social networking system.
RECTECHIV Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowRECTECHIV Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RECTECHIV Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have a physical disability that limits my ability to move around.I am currently experiencing a worsening of my health condition.I am between 18 and 64 years old.I do not have severe lung or kidney disease.I have had a heart-related event in the last 6 months.I don't have conditions that stop me from being active.I have a physical disability that limits my ability to move around.
- Group 1: intervention
- Group 2: Control
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is the enrollment criteria for this trial expansive enough to include seniors?
"This clinical trial will involve participants who are of legal age and no older than 64 years."
Who is eligible to participate in this medical experiment?
"This medical study is searching for 30 participants who have inactivity of a physical nature and are between 18-64 years old."
Is this research venture currently seeking participants?
"Data from clinicaltrials.gov suggests that this medical trial is not accepting new participants at present, despite being first posted January 1st 2023 and last edited October 24th 2022. Fortunately, there are currently 101 other trials recruiting individuals for study participation."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger